Article
Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death.
Brain : a journal of neurology - 1 Oct 2017
Thiepold Anna-Luisa, Lorenz Nadja I, Foltyn Martha, Engel Anna L, Divé Iris, Urban Hans, Heller Sonja, Bruns Ines, Hofmann Ute, Dröse Stefan, Harter Patrick N, Mittelbronn Michel, Steinbach Joachim P, Ronellenfitsch Michael W
Abstract excerpt
Glioblastomas are characterized by fast uncontrolled growth leading to hypoxic areas and necrosis. Signalling from EGFR via mammalian target of rapamycin complex 1 (mTORC1) is a major driver of cell growth and proliferation and one of the most commonly altered signalling pathways in glioblastomas. Therefore, epidermal growth factor receptor and mTORC1 signalling are plausible therapeutic targets and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
